Functional proteomics approaches have led in the past to the description of large protein-protein interaction networks. Genome-wide studies have been achieved for viruses (Bartel et al. 1996; Flajolet et al. 2000; McCraith et al. 2000) , yeast (Uetz et al. 2000; Ito et al. 2001) , and bacteria (Rain et al. 2001) . For higher eukaryotes, a comprehensive protein interaction map (Giot et al. 2003) as well as more focused studies on cell cycle factors (Finley Jr. and Brent 1994) or on homologs of human cancer-related proteins (http://pim.hybrigenics.com) were performed for Drosophila proteins. Studies on Caenorhabditis elegans with the establishment of protein interaction maps in DNA damage response (Boulton et al. 2002) and in DAF7/TGF␤ signal transduction (Tewari et al. 2004 ) followed by functional validation have also been reported. However, in mammalian cells, except the recently published study on the TNF␣/NF-B signal transduction pathway (Bouwmeester et al. 2004) , only specific studies focused on a limited set of proteins and interactions are available. A key limitation is the difficult handling of the large number of interactions that are identified through the yeast two-hybrid technology combined with the numerous specific functional analyses to be performed in order to demonstrate the biological function for each newly identified protein and/or interaction. An efficient strategy for functional exploration of complex proteomes would require (1) an in-depth annotation of protein-protein interaction maps with any type of available information on proteins, protein domains, and interactions; (2) an exploration tool that allows easy navigation in such a complex database; and (3) streamlined functional assays that would confirm implication of newly identified proteins in a specific biological and/or biochemical readout. In a model experiment, we applied this strategy to the human Smad signaling pathway.
Members of the TGF␤ superfamily (e.g., TGF␤, activins and bone morphogenetic proteins, BMPs) are secreted signaling molecules that regulate many biological processes such as cell growth, differentiation, and morphogenesis. The disruption of components of the TGF␤ superfamily pathways is associated with human diseases including fibrosis, inflammatory disorders, and cancer. The effects of these pleiotropic molecules are transduced via the ligand-induced formation of heteromeric complexes, consisting of different type I and type II serine/threonine kinase receptors (T␤RI, T␤RII; Massague 1998). Upon ligand binding, T␤RII phosphorylates and activates T␤RI, leading to the phosphorylation of receptor-activated Smads (R-Smads; Massague 1998). TGF␤ and activin receptors phosphorylate Smad2 and Smad3 Macias-Silva et al. 1996; Zhang et al. 1996) , whereas BMP receptors phosphorylate Smad1, Smad5, and Smad8 Liu et al. 1996) . The phosphorylation of R-Smads induces their release from the receptor complex and from SARA, a protein that recruits Smads to the cell membrane (Tsukazaki et al. 1998) . Phosphorylation also stimulates R-Smads to translocate to and to accumulate in the nucleus along with their common partner Smad4 (Lagna et al. 1996) . Smads then regulate target gene expression in collaboration with other transcriptional partners (ten Dijke et al. 2000) .
Here we present an integrated approach for the identification of new factors implicated in this key human signaling pathway involved in several human pathologies. We screened for protein-protein interactions with 11 Smad and related proteins, we generated a complex protein-protein interaction map that is explored through a specific bioinformatics platform, and we demonstrate via cellular assays the function of eight novel proteins involved in the Smad pathway.
RESULTS

Protein Interaction Map of the Smad Pathway
To improve our understanding of Smad signaling, we combined a large-scale yeast two-hybrid-based protein-protein interaction mapping with a systematic functional validation in mammalian cells (Fig. 1) . The two-hybrid screening process was performed using a highly complex placental cDNA library (10 million independent yeast clones). Eleven proteins known to be important actors in the Smad pathway (Smad1, 2, 3, 4, 5, 7, 8, SARA, Smurf2, SNIP1, and SnoN) were selected and used to generate 25 bait fragments for yeast two-hybrid screening. Twelve additional proteins, identified as prey in these primary screens, were also selected as bait to perform a total of 44 screens (rebound screens; see Table 1 ). The Smad interaction map was constructed using a software platform composed of a database, a Web-based graphical interface layer and various query and analysis tools (the PIMRider; see http://pim.hybrigenics.com, where all interaction data are shown). The selected interacting domains (or SID) and the functional domains of each given protein are displayed in the PIMRider. Each protein-protein interaction pair is characterized by a PBS value (Predicted Biological Score) based on a statistical model reflecting the reliability of the interaction. The PBS is divided into five categories from A (highest confidence) to E (probable false positive; Rain et al. 2001) . This confidence scoring system is possible because of the availability of a large data set of >9000 interactions identified in 410 screens against the same library (see Methods).
Our two-hybrid screening approach identified 755 interactions, corresponding to 591 different proteins potentially connected to the Smad pathway. Of these interactions, 27 have previously been shown to be involved in Smad signaling (ten Dijke et al. 2000; Attisano and Wrana 2002) . For example, Figure 2 represents the partial protein interaction map (PIM) around major members of the TGF␤ pathway. Analysis of the PIM revealed an intricate network of protein-protein interactions in this pathway. Previously characterized direct interactions between RSmads were clearly visible on the PIM. R-Smads were also found to interact with previously described partners such as Smurf1, Smurf2, SARA, SnoN, Ski, SMIF, and SIP1. Of the 99 interactions presented in this figure, 15 had been demonstrated previously. Interestingly, we identified many new interactors in the pathway such as kinases, phosphatases, transcription factors, ubiquitin ligases, and proteins of unknown function, which could be crucial for TGF␤ responses ( Fig. 2 ; PIMRider on the Web site).
Functional Validation in Mammalian Cells
To build an integrated functional proteomics platform, we combined the protein-protein interaction mapping with the systematic use of functional validation assays in mammalian cells. This "functional interaction assay" in mammalian cells allowed us to confirm the involvement of new proteins in the Smad pathway, suggested by our results of protein-protein interactions. Different interference technologies and read-out assays were thus developed to assign functions to as many proteins as possible. A set of 14 proteins was selected on the basis of interaction scores and attractive functional domain annotations or protein novelty. Rebound screens were performed with most of these 14 proteins, using the prey as bait to explore the protein network around these candidates and to confirm the interaction (Table 2) . We then used the human HepG2 cell line, which has functional TGF␤ and BMP signaling pathways, to test the involvement of these 14 proteins in the Smad pathway (Jonk et al. 1998) . The endogenous mRNA level of each candidate was first monitored for TGF␤ or BMP induction using Quantitative PCR (Q-PCR) in HepG2 cells. Only one gene was transcriptionally regulated by TGF␤ (LAPTm5; see below). In addition, we used the TGF␤-RE and BMP-RE luciferase reporters, which contain elements that respond transcriptionally to TGF␤ and BMP-7, respectively, to investigate the effect of the 14 selected proteins on the regulation of the transcriptional responses induced by TGF␤ and BMP7 (Zawel et al. 1998; Kusanagi et al. 2000) . We used these reporter constructs in transient transfection experiments to provide a read-out to allow us to monitor the effect of protein overproduction and siRNA on the Smad pathway ( Table 2 ). The overproduction of two of the selected proteins (LAPTm5 and PPP1CA) had a significant effect on the TGF␤-responsive promoter. We also used TGF␤-RE and BMP-RE in cellular knock-down experiments using chemically synthesized specific siRNA duplexes targeting each protein. The efficiency and specificity of each siRNA duplex on the levels of the endogenous and control mRNAs were systematically tested (Supplemental Table 1 ). Knock-down of seven proteins (LAPTm5, PPP1CA, MAN1, HYPA, LMO4, KIAA1196, and ZNF8) had a significant effect on TGF␤ and/or BMP signaling (Table 2 ). To assess independently the implication of these 14 selected proteins in Smad signaling, we performed similar siRNA experiments followed by Q-PCR analysis of TGF␤-or BMPregulated endogenous markers. The chosen markers were the plasminogen-activator-inhibitor Type 1 gene (PAI-1) and the alkaline phosphatase gene (AP), which are known to be induced by TGF␤ and BMP, respectively (Keeton et al. 1991; Lecanda et al. 1997) . Indeed, the siRNA-mediated knock-down of several proteins (LAPTm5, MAN1, HYPA, LMO4, RNF11, KIAA1196 and ZNF8) had a significant effect on the TGF␤-or BMP-regulated Smad signaling (Table 2) .
Thus, functional validation experiments confirmed that eight of the 14 proteins identified by two-hybrid screening are involved in the Smad pathway. While this work was in progress, four of these proteins (PPP1CA, ZNF8, MAN1, and RNF11) were shown by other groups to be involved in Smad signaling. PPP1CA was shown to bind to SARA and to regulate Decapentaplegic (Dpp) Figure 1 Strategy for unraveling interactions between components of the Smad pathway. This figure describes the global process from our large-scale yeast two-hybrid screening to the general functional validation assays in mammalian cells. Preys were selected by use of bioinformatics tools (PIMBuilder, PIMRider) and biological expertise. (Bennett and Alphey 2002) . The mouse ZNF8 protein was shown to interact with Smad1 and to be involved in the Smad pathway (Jiao et al. 2002) . The Xenopus MAN1 ortholog, SANE, was shown to interact with Smad1 and to regulate BMP signaling (Raju et al. 2003) . Our results also involve these proteins in Smad signaling in a human system and emphasize that components of Smad signaling are strongly conserved in various species, although the precise role of each of them remains to be addressed. Lastly, human RNF11 was shown to restore TGF␤ responsiveness, through its interaction with Smurf2 (Subramaniam et al. 2003) . We also identified a new interaction between RNF11 and SARA ( Fig. 2) . Involvement of these four proteins in the Smad pathway was thus confirmed by other groups, thus demonstrating the specificity and the pertinence of our experimental approach.
signaling in Drosophila melanogaster
New Factors Involved in the Smad Pathway
In addition to these four proteins, we identified four other novel proteins that are involved in the Smad pathway: LMO4, HYPA, KIAA1196, and LAPTm5.
LMO4
We identified, by yeast two-hybrid, an interaction between LMO4 and Smad8, a protein involved in the BMP pathway (see PIMRider). This result suggests that they may interact in mammalian cells, but further evidence is needed to confirm this finding. Q-PCR and reporter experiments showed that the LMO4-targeting siRNA duplex specifically repressed BMP-induced AP mRNA levels and BMP-induced reporter activity (Fig. 3A ). These findings demonstrate that this protein is involved in the regulation of the BMP pathway.
HYPA
We identified an interaction between HYPA and Smad4, suggesting that they may interact in mammalian cells (see Fig. 2 ). We also demonstrated that the HYPA-targeting siRNA duplex repressed the induction of luciferase reporter activity by TGF␤ and BMP (Fig. 3A,B) . This is in agreement with the fact that Smad4 is a common Smad involved in both TGF␤ and BMP signaling.
KIAA1196
The hypothetical zinc finger protein KIAA1196 was shown to interact with Smad1, and this finding was confirmed in rebound screen (see PIMRider). Q-PCR and reporter experiments showed that the KIAA1196-targeting siRNA duplex strongly and specifically repressed PAI-1 mRNA levels and reporter activity in a TGF␤-dependent manner (Fig. 3B) . Silencing TGF␤ signaling by use of KIAA1196 cellular knock-down demonstrated that this protein is an essential regulator of this pathway.
LAPTm5
Finally, we showed that LAPTm5 interacts with Smurf2 (see Fig.  2 ), an E3-ubiquitin ligase targeting various actors in the Smad pathway for ubiquitin-mediated proteasomal degradation (Izzi and Attisano 2004) . The region of LAPTm5 that interacts with Smurf2 corresponds to the 16 C-terminal amino acids of LAPTm5. This domain contains a PPXY motif, responsible for binding with proteins containing a WW motif, like those present in Smurf2 (Fig. 4A) . To determine the functional role of LAPTm5 in the Smad pathway, we evaluated the endogenous level of LAPTm5 mRNA in HepG2 cells. Following TGF␤ treatment, we observed a 20-fold increase in the amount of LAPTm5 mRNA (Fig. 4B ). This induction was TGF␤-specific as it was totally abolished in the presence of a T␤RI-targeting siRNA duplex (Fig. 4B) shown to inhibit TGF␤ signaling (Fig. 4D) . Furthermore, BMP Twenty-three different proteins were used as bait fragments. The GenBank accession number of each protein is given. These proteins were divided into several fragments (v1, v2, v3, v4) to generate 44 different bait clones. The amino acid positions of each fragment are given in parentheses.
treatment had no effect on LAPTm5 mRNA levels in HepG2 cells (data not shown). We next investigated the effect of LAPTm5 overproduction on TGF␤ and BMP-responsive reporters. The overproduction of LAPTm5 resulted in a dose-dependent decrease in TGF␤ reporter luciferase activity in HepG2 cells. The overproduction of LAPTm5 had no effect on the BMP reporter or on a control reporter, demonstrating the specificity of LAPTm5 for TGF␤ signaling (Fig. 4C) . Consistent with our data in the overexpression system, Q-PCR experiments in HepG2 cells showed that LAPTm5-targeting siRNA duplexes enhanced the TGF␤-mediated up-regulation of PAI-1 mRNA (Fig. 4D) . Taken together, these results demonstrate that LAPTm5 is a negative regulator of the TGF␤ pathway.
DISCUSSION
Here, we describe an integrated study of a human signaling pathway starting from protein interaction map to functional assays in mammalian cells. We identified a network of 755 proteinprotein interactions in the Smad pathway. The use of PIMRider, a dedicated navigation tool accessible through our Web site (http://pim.hybrigenics.com), dramatically improved the exploration of such complex interaction databases. Our functional proteomic mapping of this pathway resulted in the biological validation of eight proteins connected to this signaling. In this set of proteins, four were recently shown to be involved in Smad signaling by other groups. We have shown the involvement of four additional proteins in regulation of TGF␤ and/or BMP pathways. LMO4, an Smad8-interacting partner, is down-regulated in prostate cancer and overexpressed in human breast cancer cell lines and in primary invasive breast carcinomas (Visvader et al. 2001) . LMO4 also represses BRCA1-mediated transcriptional activation in mammalian cells, suggesting a repression of BRCA1 activity in breast tissue (Sum et al. 2002 ). An additional role in transcriptional regulation can now be assigned to LMO4 because we demonstrated the involvement of LMO4 in the regulation of the BMP pathway.
HYPA has been shown to interact with huntingtin, a protein implicated in Huntington's disease. This protein, also called FBP11, is the human homolog of the essential pre-mRNA splicing factor PrP40 (Faber et al. 1998) . HYPA was shown here to be involved in both TGF␤ and BMP signaling, presumably by interacting with Smad4, the Smad protein common to both pathways.
KIAA1196 is an example of the numerous genes present in our interaction database with no known function so far. As KIAA1196 displays seven zinc fingers and a leucine zipper, it may act as a transcription factor. We demonstrated that knocking down this putative transcription factor leads to a strong inhibition of the TGF␤ pathway. However, additional experiments are required to explain the specific modulation of TGF␤ signaling by this Smad1-interacting protein.
The LAPTm5 protein contains five transmembrane domains and is located in the lysosomal membrane (Adra et al. 1996) . LAPTm5 is up-regulated in Sjögren's syndrome, a chronic autoimmune disease (Azuma et al. 2002) , and in malignant B lymphomas (Seimiya et al. 2003) . LAPTm5 is also coexpressed with activated macrophage genes in rheumatoid arthritis (Walker 2002) . GCD-10, the LAPTm5 ortholog in rats, was found to be activated in response to neuronal apoptosis (Origasa et al. 2001) . 
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Recently, inactivation of the LAPTm5 gene was observed in human multiple myeloma (Hayami et al. 2003) . Although this protein is structurally related to a family of lysosomal transporter proteins that regulate cellular multidrug resistance (Cabrita et al. 1999) , its function remained unknown. We identified LAPTm5 as a Smurf2-interacting partner. Smurf2 is an E3 ubiquitin ligase involved in the degradation of TGF␤ signaling components, including receptor and Smad proteins (Izzi and Attisano 2004) . In addition, rebound screening experiments using LAPTm5 as bait confirmed the interaction between Smurf2 and LAPTm5 and allowed us to identify new LAPTm5 protein partners, including ubiquitin, other E3 ubiquitin ligases, and proteins involved in endocytosis. Many of these partners were also found when the putative E3 ubiquitin ligase, RNF11, was used as bait. These results describe an intimate network of protein interactions between LAPTm5 and proteins involved in protein degradation. It has been suggested that Smurf2 targets TGF␤ receptors and Smad7 to lysosomal and proteasomal degradation (Kavsak et al. 2000) . Our results suggest that LAPTm5 might be a smurf2 receptor at the lysosomal membrane and might address some TGF␤ signaling members to the lysosomal compartment to induce their degradation, resulting in inhibition of the TGF␤ pathway. In addition, we show that LAPTm5 is transcriptionally activated by TGF␤, suggesting a potential feedback mechanism. In accordance with this induction by TGF␤, we identified two putative consensus Smad binding elements (Dennler et al. 1998) in the LAPTm5 promoter at positions ‫4661מ‬ and ‫564מ‬ with respect to the ATG start site.
These results give many insights about the involvement of several proteins in the Smad pathway, but the precise role and mechanism of action of each of them remains to be further characterized. For this study, we used functional assays based on Smad transcriptional responses. Other functional assays, addressing different biological mechanisms such as Smad or receptor phosphorylation, protein stability, or proliferation rate, could be used to validate the other proteins identified in our Smadinteraction database and available through the PIMRider. Our results demonstrate that a large-scale protein-protein interaction map combined with general functional validation in mammalian cells is of great help in identifying new components of the Smad signaling. This experimental strategy can be applied to other human transduction signals and could considerably increase our knowledge of many of the numerous recently sequenced genes.
METHODS Yeast Two-Hybrid Screening
Baits were PCR-amplified (Pfu; Stratagene) and cloned into a plasmid derived from pBTM116 (Vojtek and Hollenberg 1995). The fragments corresponding to the initial baits are described in Table 1 . Randomly primed cDNA libraries from human placenta poly(A) + RNA were constructed in a prey plasmid derived from pGADGH (Bartel 1993) . The libraries were used to transform the Y187 yeast strain, and 10 million independent yeast colonies were collected, pooled, and stored at ‫°08מ‬C as equivalent aliquot fractions of the same library. The mating protocol was as described previously (Rain et al. 2001) . Each screen was performed to ensure that a minimum of 50 million interactions were tested. The prey fragments of the positive clones were PCR-amplified 
Proteins used as bait fragments for this selection of prey proteins in yeast two-hybrid screening are indicated (bait proteins). Rebound screening was performed for most of these proteins (nd: not done): a "+" indicates that the selected protein was used in a rebound screen and that interaction was found again. A ‫"מ"‬ indicates that the selected protein was used in a rebound screen but that interaction was not found again. The mRNA level of each candidate was monitored for TGF␤ or BMP induction using Q-PCR in HepG2 cells. TGF␤ and BMP7-responsive luciferase reporters were transfected in HepG2 cells to monitor the effect of the selected proteins' overproduction or siRNA transfection. Reporter assays were normalized using the pRL-TK vector as an internal control. The endogenous expression of the PAI-1 gene or the AP gene was determined in the presence of TGF␤ or BMP7 after siRNA transfection, respectively. All Q-PCR results were normalized using GUS as a standard control. Note that reporter or mRNA gene expression was detected above background in each experimental condition. The symbols ( ) and (᭢) correspond to up-regulation and downregulation by the selected protein, respectively. (nd) not done, ‫)מ(‬ no significant effect, (+) slight but significant effect (<twofold), (++) a twofold to fourfold effect, and (+++) indicates a strong effect (>fourfold). Triplicates were performed in at least two independent experiments. and sequenced at their 5Ј and 3Ј junctions on a PE3700 Sequencer. The resulting sequences were used to identify the corresponding gene in the GenBank database (NCBI) using a fully automated procedure.
Plasmid Construction
The pV3 and pV7 expression vectors, prepared from pfastbac1 vectors (Invitrogen), contain a CMV promoter that controls the production of our proteins of interest fused to the FLAG or GST epitope, respectively. All genes cloned in pV3 were obtained by PCR amplification from the placental cDNA library. The MLP minimal promoter from an adenovirus Major Late gene, containing a TATA-box and an initiator element, was cloned into the pGL3 basic vector (Promega) to generate the MLP-Luc plasmid.
To construct TGF␤-RE, eight copies of the GTCT-box, a TGF␤-responsive sequence (Zawel et al. 1998) , were cloned into the MLP-Luc plasmid. To construct BMP-RE, 12 copies of the GCbox, a BMP-responsive sequence (Kusanagi et al. 2000) , were cloned into the MLP-Luc plasmid. All these constructs were sequenced.
Luciferase Assays
HepG2 cells were transiently transfected using Fugene 6 (Roche) according to the manufacturer's recommendations. Then, 18 h after TGF␤1 or BMP7 stimulation (10 ng/mL or 50 ng/mL, respectively), luciferase activity was measured using the Dual Luciferase reporter assay kit (Promega) in a luminometer (BMG). Values were normalized with respect to the Renilla luciferase activity expressed from pRL-TK.
Quantitative PCR Assays
HepG2 cells were lysed and RNA was extracted according to the manufacturer's recommendations (QIAGEN). The reverse transcription step was performed in 96-well plates using the TaqMan reverse transcription kit (Applied Biosystems) according to the manufacturer's recommendations. The cDNA was quantified by the SyBR green method using a SyBR Green PCR master Mix kit (Applied Biosystems). Experiments were carried out using an Applied Biosytems 7000 SDS. Oligonucleotides were validated by Q-PCR experiments to obtain a quantitative measurement (quantification of serially diluted cDNA and determination of PCR efficiency). The marker used for TGF␤ signaling was the plasminogen activator-inhibitor type 1 gene (PAI-1). The marker used for BMP signaling was the alkaline phosphatase gene (AP). Values were normalized according to the ␤-glucoronidase (GUS) gene, which was measured as internal control.
siRNA Design and Transfection siRNAs synthesized chemically using RNA phosphoramidites were purchased from Proligo. All siRNA duplexes were designed as described by Tuschl and colleagues (Elbashir et al. 2001) . As a validation experiment, the efficiency of these siRNAs for their targeted mRNAs was tested by Q-PCR. All siRNAs inhibited the amount of their targeted mRNA by between 65% and 95%, and none of them affected significantly another unrelated mRNA (GUS). The specific silencing of the targeted genes was confirmed by at least two paired triplicate experiments (Supplemental Table  1 ). siRNAs targeting the validated proteins (LMO4, HYPA, and LAPTm5) were also checked for their efficiency and specificity by Western blot after cotransfection of a vector encoding for the GST-protein of interest (500 ng per well) and the corresponding siRNA (40 nM per well) in the HEK293 cell line (Supplemental Fig. 1 
Bioinformatics
The protein interaction mapping was supported by a dedicated Laboratory Information Management System (LIMS), the PIMBuilder. For every yeast two-hybrid screen, 5Ј and 3Ј sequences of all positive clones were determined and filtered by use of PHRED (Ewing and Green 1998) and by masking ALU repeats. Sequence contigs were then built using CAP3 (Huang and Madan 1999) and compared with the latest release of GenBank using BLASTN (Altschul et al. 1997) . If GenBank entries corresponding to the complete mRNA are found, the best annotated entry, preferentially from the RefSeq division of GenBank, is assigned to every overlapping prey fragment family. The SID (Selected Interacting Domain) is the common part of all fragments in a family. This region contains the domain that interacts with the bait. Each two-hybrid screening experiment generates a list of bait-SID interactions. The PIM (Protein Interaction Map) is then built by pooling all the bait-SID interactions from several screens. The method for calculating PBS, previously described for genomic libraries (Rain et al. 2001) , was adapted for randomly primed cDNA libraries. The PBS value represents the probability of a protein-protein interaction being nonspecific. It ranges from 0 to 1, but was grouped in five categories (A, B, C, D, and E) for user convenience. Intercategory thresholds were chosen manually with respect to a training data set containing known true-positive and falsepositive interactions (data not shown): A < 1e-10 < B < 1e-5 < C < 1e-2.5 < D < 1; the E category corresponds to SIDs nonspecifically selected by baits (Rain et al. 2001 ) and for which the corresponding PBS was set to 1. A PBS confidence score was assigned to each protein-protein interaction in the map. In addition, proteins connected in the PIM were automatically annotated in terms of structural and functional domains by use of bioinformatics algorithms: TMHMM (Krogh et al. 2001) and SignalP (Nielsen et al. 1997) for the detection of transmembrane helices and signal peptides, respectively, and IpScan for the prediction of InterPro domains (Apweiler et al. 2001) . Predicting InterPro domains allows proteins to be clustered into functional categories like those defined in the Gene Ontology (GO) classification (Ashburner et al. 2000) . Finally, the annotated PIM can be explored by use of the PIMRider visualization platform, developed in-house, which includes four viewers: the ProteinViewer, which displays textual annotations for a given protein, the list of interacting partners, and the sequence ( Supplemental  Fig. 2) ; the PIMViewer, which displays a graphical and dynamic view of protein interaction networks ( Fig. 2 ; Supplemental Fig. 3) ; the InteractionViewer, which gives access to raw experimental data on prey, bait, and SID sequences (Supplemental Fig. 4) ; and the DomainViewer, which displays and makes it possible to compare, for one protein and all its partners in the map, domains and motifs extracted from both experimental (bait and SID) and calculated (transmembrane segments, signal peptides, and functional InterPro domains) analyses (Supplemental Fig. 5 ). 
